Gennex Laboratories Limited (BOM:531739)
India · Delayed Price · Currency is INR 11.22
+0.48 (4.47%)
At close: Mar 5, 2026
Gennex Laboratories Market Cap
Gennex Laboratories has a market cap or net worth of 2.73 billion as of March 5, 2026. Its market cap has decreased by -4.66% in one year.
Market Cap
2.73B
Enterprise Value
3.22B
Revenue
1.52B
Ranking
n/a
PE Ratio
15.02
Stock Price
11.22
Market Cap Chart
Since January 2, 2002, Gennex Laboratories's market cap has increased from 61.80M to 2.73B, an increase of 4,310.55%. That is a compound annual growth rate of 16.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 2.61B | -19.78% |
| Dec 31, 2025 | 3.25B | -12.43% |
| Dec 31, 2024 | 3.71B | 24.52% |
| Dec 29, 2023 | 2.98B | 160.77% |
| Dec 30, 2022 | 1.14B | -18.17% |
| Dec 31, 2021 | 1.40B | 135.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medico Remedies | 3.54B |
| Everest Organics | 3.52B |
| Amanta Healthcare | 3.44B |
| ZIM Laboratories | 3.39B |
| Trident Lifeline | 3.20B |
| Kerala Ayurveda | 2.61B |
| Sat Kartar Life | 2.60B |
| Sanjivani Paranteral | 2.30B |